Hem › Ulcerös kolit › Tennessee
Kliniska studier för Ulcerös kolit i Tennessee
12 studier för Ulcerös kolit söker deltagare vid platser i Tennessee.
Städer i Tennessee
Officiell studietext (engelska)
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Gastrointestinal Associates - Knoxville - Dowell Springs Boulevard /ID# 283861, Knoxville
- Gastro One - Memphis /ID# 283948, Memphis
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 2 okt. 2026 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Tri-Cities Gastroenterology, Kingsport
RekryterarFas 4
Ålder 18 till 80 · Alla kön · Uppdaterad 30 sep. 2026 · NCT06581328Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
- Xencor Investigative Site, Cordova
RekryterarFas 1/2Friska volontärer välkomna
Ålder 18 till 75 · Alla kön · Uppdaterad 29 sep. 2026 · NCT06619990A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 017, Kingsport
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 29 sep. 2026 · NCT07012395A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- Site US-003, Cordova
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 29 sep. 2026 · NCT07845487Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Gastroenterology Center Of The Midsouth, Cordova
RekryterarFas 3
Ålder 18 till 70 · Alla kön · Uppdaterad 24 sep. 2026 · NCT06937086LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Gastro One - Walnut Run Road, Cordova
RekryterarFas 2
Ålder 18 till 80 · Alla kön · Uppdaterad 22 sep. 2026 · NCT07186101LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Skyline Gastroenterology of West Tennessee, Jackson
RekryterarFas 2
Ålder 18 till 80 · Alla kön · Uppdaterad 22 sep. 2026 · NCT07415044A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
- Gastro One, Cordova
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 28 aug. 2026 · NCT07577856Study to Evaluate the Efficacy and Safety of Ponesimod (VSP-128) in Patients With Moderately to Severely Active Ulcerative Colitis
- Vanda Investigational Site, Nashville
RekryterarFas 3
Ålder 18 till 75 · Alla kön · Uppdaterad 18 aug. 2026 · NCT07686081A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Cordova
RekryterarFas 2
Ålder 18 till 80 · Alla kön · Uppdaterad 12 mars 2026 · NCT07113522Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention
- Vanderbilt University, Nashville
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 8 maj 2025 · NCT06750731Från ClinicalTrials.gov, data hämtad 3 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.